Petr Vladimirovich Kruglyakov
Chief Executive Officer at PHARMSYNTHEZ
Petr Vladimirovich Kruglyakov active positions
Companies | Position | Start | End |
---|---|---|---|
PHARMSYNTHEZ | Chief Executive Officer | 01/01/2014 | - |
Director/Board Member | 01/01/2015 | 01/01/2016 | |
Chief Operating Officer | 01/01/2013 | 01/01/2014 |
Career history of Petr Vladimirovich Kruglyakov
Former positions of Petr Vladimirovich Kruglyakov
Companies | Position | Start | End |
---|---|---|---|
SynBio LLC
SynBio LLC Pharmaceuticals: MajorHealth Technology SynBio LLC engages in original research and introduction of conceptually new medicines. The firm’s medicines help treat diseases like liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes milletus. Its work is based on scientific developments and conducted in cutting edge laboratories. The company was founded in 2011 and is headquartered in Moscow, Russian Federation. | Chief Executive Officer | 01/01/2011 | 01/01/2013 |
Corporate Officer/Principal | 01/01/2013 | 01/01/2014 | |
HUMAN STEM CELLS INSTITUTE | Chief Tech/Sci/R&D Officer | 01/01/2010 | 01/01/2011 |
Training of Petr Vladimirovich Kruglyakov
State University of St. Petersburg | Undergraduate Degree |
Statistics
International
Russia | 5 |
Operational
Chief Executive Officer | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 3 |
Health Services | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
HUMAN STEM CELLS INSTITUTE | Health Services |
PHARMSYNTHEZ | Health Technology |
Private companies | 1 |
---|---|
SynBio LLC
SynBio LLC Pharmaceuticals: MajorHealth Technology SynBio LLC engages in original research and introduction of conceptually new medicines. The firm’s medicines help treat diseases like liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes milletus. Its work is based on scientific developments and conducted in cutting edge laboratories. The company was founded in 2011 and is headquartered in Moscow, Russian Federation. | Health Technology |